Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Phase II trial of repifermin for chronic venous ulcers does not meet primary endpoint

Sep. 30, 2003

Cytochroma selects drug candidate for treatment of psoriasis

Sep. 26, 2003

New CCR3 antagonist with oral activity in animal model of atopic dermatitis

Sep. 25, 2003

Increased expression of constitutive proteins in burned children treated with oxandrolone

Sep. 23, 2003

IsoTis signs licensing agreement for Allox

Sep. 23, 2003

SBIR grant awarded for clinical trials of rhLF for diabetic foot ulcers

Sep. 22, 2003

Clinical benefits of topical PTH(1-34) cream in chronic plaque psoriasis

Sep. 22, 2003

Novel glucocorticoid agonists and their use

Sep. 18, 2003

Raptiva recommended for approval by advisory committee

Sep. 15, 2003

Inhibitors of procollagen C-endopeptidase synthesized and evaluated as potential antifibrotic agents

Sep. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...